Machine Learning

A new report warns that rapid AI adoption has created a vast, invisible risk landscape where cyber threats are outpacing organizations' ability to defend.

At ViVE 2026, a live podcast aims to prove the future of medicine is not just in new drugs, but in the intelligence hidden within diagnostic data.

SUSE's strategic purchase of Losant aims to create the first full-stack, open-source IIoT platform, challenging proprietary giants at the 'tiny edge'.

Sequel Med Tech and Senseonics launch a groundbreaking system pairing a year-long glucose monitor with an automated insulin pump, reshaping daily life for many.

As federal funding dwindles and supply costs soar, universities are adopting AI procurement solutions like Labviva to protect the future of scientific discovery.

Cloud security leader Zscaler prepares for high-stakes investor conferences, aiming to showcase its financial strength and AI-driven growth strategy.

Last-mile leader OneRail opens a new engineering hub in Kraków, leveraging Poland's elite talent to accelerate its AI-native platform innovation.

Clene Inc. faces investors with promising data for ALS and MS, but a looming cash crunch makes its upcoming conference a critical test of survival.

An international team receives a major grant to use artificial intelligence to predict survival and treatment response, offering new hope for a deadly disease.

FinTech leader Derivative Path promotes Zack Nagelberg to President, signaling a strategic push into AI-driven risk management for evolving capital markets.

A new study finds 88% of software teams prioritize AI for testing, but deep-seated fears about accuracy and reliability are holding back adoption.

Reunion Neuroscience hits the investor conference circuit, seeking capital to advance its groundbreaking psychedelic-inspired therapies for depression and anxiety.

With new kits for complex cell models, Atrandi's semi-permeable capsules challenge market leaders by enabling multi-step workflows previously out of reach.

With two strategic hires from TriNetX and Canon Medical, Avandra signals an aggressive push to unlock siloed medical imaging data for research and AI.

Reaching over 90% of German mobile users, a new partnership aims to restore trust in the phone by displaying verified business names on incoming calls.

After a volatile market debut, the supersonic flight company hits the NYSE, signaling a new era for high-speed testing and air-launch services.

New five-year data for SYFOVRE shows a significant delay in geographic atrophy progression, offering long-term hope but also sparking clinical debate.

A new partnership between WELL Health and HEALWELL AI uses artificial intelligence to find trial participants, but puts patient consent at the forefront.

At a major scientific conference, Seer Inc.'s Proteograph platform is taking center stage, promising deeper insights into Alzheimer's and heart disease.

With a pivotal data release on the horizon, Passage Bio heads to two major conferences. Can its dementia gene therapy program win over Wall Street?